Suppr超能文献

益生菌补充剂和运动训练对非酒精性脂肪性肝病患者肝酶和心脏代谢标志物的影响:一项随机临床试验的系统评价和荟萃分析

The effects of probiotic supplementation and exercise training on liver enzymes and cardiometabolic markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials.

作者信息

Kazeminasab Fatemeh, Miraghajani Maryam, Mokhtari Khatereh, Karimi Bahareh, Rosenkranz Sara K, Santos Heitor O

机构信息

Department of Physical Education and Sport Sciences, Faculty of Humanities, University of Kashan, Kashan, Iran.

Department of Cancer Research Center, Shahid Beheshti of Medical Sciences, Tehran, Iran.

出版信息

Nutr Metab (Lond). 2024 Aug 1;21(1):59. doi: 10.1186/s12986-024-00826-8.

Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver ailment worldwide, in which nonpharmacological strategies have a considerable role in the treatment. Probiotic supplementation as well as physical exercise can improve cardiometabolic parameters, but further research is needed to determine the effects of combined treatment versus exercise alone in managing NAFLD-associated biomarkers, primarily liver enzymes, lipid markers, and insulin resistance.

OBJECTIVES

This systematic review and meta-analysis aimed to evaluate the effects of probiotic supplementation, combined with exercise versus exercise alone, on liver enzymes and cardiometabolic markers in patients with NAFLD.

METHODS

A systematic review and meta-analysis of randomized clinical trials was performed by searching PubMed, Scopus, and Web of Science databases up to April 2024. The search was restricted to articles published in the English language and human studies. Random effects models were used to calculate weighted mean differences (WMD).

RESULTS

Pooled estimates (9 studies, 615 patients, intervention durations ranging from 8 to 48 weeks) revealed that probiotics plus exercise decreased aspartate transaminase (AST) [WMD=-5.64 U/L, p = 0.02], gamma-glutamyl transferase (GGT) [WMD=-7.09 U/L, p = 0.004], low-density lipoprotein (LDL) [WMD=-8.98 mg/dL, p = 0.03], total cholesterol (TC) [WMD=-16.97 mg/dL, p = 0.01], and homeostatic model assessment for insulin resistance (HOMA-IR) [WMD=-0.94, p = 0.005] significantly more than exercise only. However, probiotics plus exercise did not significantly change high-density lipoprotein (HDL) [WMD = 0.07 mg/dL, p = 0.9], fasting insulin [WMD=-1.47 µIU/mL, p = 0.4] or fasting blood glucose (FBG) [WMD=-1.57 mg/dL, p = 0.3] compared with exercise only. While not statistically significant, there were clinically relevant reductions in alanine aminotransferase (ALT) [WMD=-6.78 U/L, p = 0.1], triglycerides (TG) [WMD=-21.84 mg/dL, p = 0.1], and body weight (BW) [WMD=-1.45 kg, p = 0.5] for probiotics plus exercise compared with exercise only. The included studies exhibited significant heterogeneity for AST (I = 78.99%, p = 0.001), GGT (I = 73.87%, p = 0.004), LDL (I = 62.78%, p = 0.02), TC (I = 72.41%, p = 0.003), HOMA-IR (I = 93.86%, p = 0.001), HDL (I = 0.00%, p = 0.9), FBG (I = 66.30%, p = 0.01), ALT (I = 88.08%, p = 0.001), and TG (I = 85.46%, p = 0.001). There was no significant heterogeneity among the included studies for BW (I = 0.00%, p = 0.9).

CONCLUSION

Probiotic supplementation combined with exercise training elicited better results compared to exercise alone on liver enzymes, lipid profile, and insulin resistance in patients with NAFLD.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO registration number CRD42023424290.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是全球最常见的慢性肝病,非药物治疗策略在其治疗中发挥着重要作用。补充益生菌以及进行体育锻炼均可改善心脏代谢参数,但需要进一步研究以确定联合治疗与单独锻炼对NAFLD相关生物标志物(主要是肝酶、血脂指标和胰岛素抵抗)的影响。

目的

本系统评价和荟萃分析旨在评估补充益生菌联合运动与单独运动相比,对NAFLD患者肝酶和心脏代谢标志物的影响。

方法

通过检索截至2024年4月的PubMed、Scopus和Web of Science数据库,对随机临床试验进行系统评价和荟萃分析。检索仅限于以英文发表的文章和人体研究。采用随机效应模型计算加权平均差(WMD)。

结果

汇总估计(9项研究,615例患者,干预持续时间为8至48周)显示,益生菌加运动组降低天冬氨酸转氨酶(AST)[WMD=-5.64 U/L,p = 0.02]、γ-谷氨酰转移酶(GGT)[WMD=-7.09 U/L,p = 0.004]、低密度脂蛋白(LDL)[WMD=-8.98 mg/dL,p = 0.03]、总胆固醇(TC)[WMD=-16.97 mg/dL,p = 0.01]和胰岛素抵抗稳态模型评估(HOMA-IR)[WMD=-0.94,p = 0.005]的幅度显著大于单纯运动组。然而,与单纯运动相比,益生菌加运动组并未显著改变高密度脂蛋白(HDL)[WMD = 0.07 mg/dL,p = 0.9]、空腹胰岛素[WMD=-1.47 µIU/mL,p = 0.4]或空腹血糖(FBG)[WMD=-1.57 mg/dL,p = 0.3]。虽然无统计学意义,但与单纯运动相比,益生菌加运动组的丙氨酸转氨酶(ALT)[WMD=-6.78 U/L,p = 0.1]、甘油三酯(TG)[WMD=-21.84 mg/dL,p = 0.1]和体重(BW)[WMD=-1.45 kg,p = 0.5]有临床相关的降低。纳入的研究在AST(I = 78.99%,p = 0.001)、GGT(I = 73.87%,p = 0.004)、LDL(I = 62.78%,p = 0.02)、TC(I = 72.41%,p = 0.003)、HOMA-IR(I = 93.86%,p = 0.001)、HDL(I = 0.00%,p = 0.9)、FBG(I = 66.30%,p = 0.01)、ALT(I = 88.08%,p = 0.001)和TG(I = 85.46%,p = 0.001)方面表现出显著异质性。纳入的研究在BW方面无显著异质性(I = 0.00%,p = 0.9)。

结论

与单独运动相比,补充益生菌联合运动训练在改善NAFLD患者的肝酶、血脂谱和胰岛素抵抗方面效果更好。

系统评价注册

PROSPERO注册号CRD42023424290。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abac/11293022/81f020865d75/12986_2024_826_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验